F. Mehl

Type de document

Articles (7)

Co-auteur

Date

Source

Mot-clé

abords (agglomération) (5) analyse (4) Analysis (4) thérapie (3) Treatment (3) Therapeutics (3) Non-insulin-dependent diabetes (3) Mice (3) Human beings (3) Insulin (3) Glucose (3) Biochemical markers (3) recherche (2) modèle (2) acide (2) maladie (2) Development (2) Control (2) Implements (2) Identification (2) Metabolites (2) Rates (2) Tools (2) Toleration (2) Tissues (2) Research (2) Mass (2) Identification (2) Homeostasis (2) Growth (2)

Documents écrit par F. Mehl (7) | parle de F. Mehl (0)

A Federated Database for Obesity Research: An IMI-SOPHIA Study.
C. Delfin et al. (16 févr. 2024)
Identification of biomarkers for glycaemic deterioration in type 2 diabetes.
R.C. Slieker et al. (3 mai 2023)
Regenerating islet-derived protein 3α: A promising therapy for diabetes. Preliminary data in rodents and in humans.
A. Le Lay et al.
Plasma triacylglycerols are biomarkers of β-cell function in mice and humans.
C. Roujeau et al.
Mechanistic insights into bacterial metabolic reprogramming from omics-integrated genome-scale models.
N. Hadadi et al. (2020)
Molecular Biomarkers of Neovascular Age-Related Macular Degeneration With Incomplete Response to Anti-Vascular Endothelial Growth Factor Treatment.
I. Mantel et al. (2020)
LC-HRMS data as a result of untargeted metabolomic profiling of human cerebrospinal fluid.
F. Mehl et al.